FDA NDC Directory · JSON-LD · Markdown

NEUPOGEN

NDC 55513-546 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameFilgrastim
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA103353
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsFILGRASTIM (480 ug/1.6mL)
Marketing started19970407
Package count2

External sources

Source: openFDA. Public-domain (CC0).